Dendreon

3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 08/10/13 - 12:24 pm
Dendreon
Merrimack Pharmaceuticals
Novavax
Dendreon retreats after earnings miss, Provenge warning
The Fly on the Wall
Fri, 08/9/13 - 01:05 pm
Dendreon
earnings
Provenge
Dendreon says sales of prostate cancer therapy Provenge won't grow in 2013; shares fall
Yahoo/AP
Thu, 08/8/13 - 06:50 pm
prostate cancer
Dendreon
Provenge
Dendreon (DNDN) Expected to Report Narrower Loss
Forbes
Tue, 08/6/13 - 10:57 am
Dendreon
earnings
Merck Needs Acquisitions: Here's The List
Seeking Alpha
Tue, 07/23/13 - 12:07 pm
Merck
M&A
Celgene
Dendreon
Endocyte
Immunomedics
Isis Pharmaceuticals
Vical
ONYX Pharmaceuticals
ImmunoCellullar Therapeutics' Immune Modifying Approach To Cancer Is Worth Watching
Seeking Alpha
Tue, 07/2/13 - 01:36 am
ImmunoCellular Therapeutics
cancer
Dendreon
ICT-107
Breaking Down Dendreon's European Recommendation
Motley Fool
Mon, 07/1/13 - 01:06 pm
Provenge
Europe
Dendreon
prostate cancer
Dendreon Surges After Cancer Drug Gets European Backing
Bloomberg
Fri, 06/28/13 - 10:33 am
prostate cancer
Europe
Dendreon
Provenge
10 Most-Shorted Biotech Stocks of 2013
TheStreet.com
Thu, 06/20/13 - 12:24 pm
InterMune
Hyperion
Arena Pharmaceuticals
Sunesis
Synta Pharmaceuticals
Ziopharm
MannKind
Dendreon
Spectrum Pharmaceuticals
Sarepta Therapeutics
Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha
Tue, 06/18/13 - 09:50 am
anti-PD-1 immunotherapy
Dendreon
Merck
Bristol-Myers Squibb
Baxter International
Yervoy
Provenge
lambrolizumab
MPDL3208A
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
biotech
Alkermes
Celgene
AstraZeneca
Coronado Biosciences
Dendreon
Incyte
Isis Pharmaceuticals
JNJ
Eli Lilly
Merck
Novavax
Novartis
Pfizer
Sangamo BioSciences
Pharmacyclics
Dendreon Analysts Getting Very Skeptical
Seeking Alpha
Wed, 05/22/13 - 11:52 am
Dendreon
Once Heralded Dendreon May Be Approaching The End Of Its Financial Road
Seeking Alpha
Tue, 05/14/13 - 05:26 pm
Dendreon
Dendreon: Picking Through the Carnage (video)
Motley Fool
Sun, 05/12/13 - 10:57 am
Dendreon
Dendreon Earnings Show Poor Provenge Sales, Implosion Risk Rising
24/7 Wall St.
Fri, 05/10/13 - 12:47 pm
Dendreon
earnings
Bracing For Dendreon Q1 2013 Earnings - All Eyes On Provenge
Seeking Alpha
Wed, 05/8/13 - 09:25 am
Dendreon
earnings
Provenge
SEC Probes Former Dendreon CEO Stock Sales
Pharmalot
Tue, 04/30/13 - 09:50 am
SEC
Dendreon
Mitchell Gold
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Understanding Why Cancer Vaccines Fail
Motley Fool
Mon, 04/1/13 - 10:46 am
cancer
vaccines
Dendreon
Provenge
Bristol-Myers Squibb
Yervoy
Sanofi
TheraCys
ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107
Seeking Alpha
Wed, 03/27/13 - 12:00 pm
ImmunoCellular Therapeutics
Dendreon
Northwest Biotherapeutics
ICT-107

Pages